Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Phase 3 Data Show That TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-12-12 09:00
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP) 2021-12-10 23:38
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx 2021-12-10 15:15
Trajan to acquire LEAP PAL Parts 2021-12-09 21:00
The innovative software "CAAS vFFR" by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness of the vessel Fractional Flow Reserve (vFFR) guided revascularization as compared to conventional FFR guided revascularization 2021-12-09 21:00
Sciwind Biosciences Completes Enrollment in Phase 2 Clinical Trial of XW003 in Type 2 Diabetes Patients 2021-12-09 20:00
Frost & Sullivan Honors Disruptive Organizations in the Region with Prestigious Industry Awards 2021-12-09 19:32
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups 2021-12-09 11:24
WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan 2021-12-09 08:00
Treadwell Therapeutics Announces A Presentation at the 2021 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor 2021-12-08 20:00
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again 2021-12-08 18:22
Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse 2021-12-08 14:00
GSK Provides Update on Manufacturing Operations in Singapore 2021-12-08 09:30
Henlius' Phase 3 clinical study of novel PD-1 inhibitor serplulimab for the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC) meets primary study endpoint 2021-12-08 08:30
CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants 2021-12-07 22:00
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting 2021-12-07 21:35
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting 2021-12-07 21:32
I-Mab to Pursue Dual Listing Plan on The Main Board of The Stock Exchange of Hong Kong Limited 2021-12-07 21:00
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant 2021-12-07 18:18
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
1 192 193 194 195 196 440